FoxO proteins in the nervous system

Analytical Cellular Pathology

Volumn 2015, Issue , 2015, Pages

  Maiese, Kenneth ^a  

^a Laboratory of Cellular and Molecular Signaling   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GLUCOCORTICOID INDUCIBLE PROTEIN KINASE; I KAPPA B KINASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; SIRTUIN 1; TRANSCRIPTION FACTOR FOXO; UNCLASSIFIED DRUG; WNT PROTEIN;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; AUDITORY NEURONAL DISEASE; AUTOPHAGY; BIOLOGICAL FUNCTIONS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; EPIGENETICS; HUMAN; HUNTINGTON CHOREA; MORBIDITY; MORTALITY; NERVE CELL DIFFERENTIATION; NERVE DEGENERATION; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; ANIMAL; GENETIC EPIGENESIS; GENETICS; METABOLISM; NERVOUS SYSTEM; PATHOLOGY;

ANIMALS; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; OXIDATIVE STRESS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84931063716     PISSN: 22107177     EISSN: 22107185     Source Type: Journal    
DOI: 10.1155/2015/569392     Document Type: Review

References (265)

1. C. M. Filley, Y. D. Rollins, C. Alan Anderson et al., "Te genetics of very early onset Alzheimer disease," Cognitive and Behavioral Neurology, vol. 20, no. 3, pp. 149-156, 2007.
2. K. Maiese, "Taking aim at Alzheimer's disease through the mammalian target of rapamycin," Annals of Medicine, vol. 46, no. 8, pp. 587-596, 2014.
3. K. Maiese, "Cutting through the complexities of mTOR for the treatment of stroke," Current Neurovascular Research, vol. 11, no. 2, pp. 177-186, 2014.
4. P. E. Pergola, C. L. White, J. M. Szychowski et al., "Achieved blood pressures in the secondary prevention of small subcortical strokes (SPS3) study: challenges and lessons learned," American Journal of Hypertension, vol. 27, no. 8, pp. 1052-1060, 2014.
5. D. Pineda, C. Ampurdańes, M. G. Medina et al., "Tissue plasminogen activator induces microglial infammation via a noncatalytic molecular mechanism involving activation of mitogen-activated protein kinases and Akt signaling pathways and AnnexinA2 and Galectin-1 receptors," Glia, vol. 60, no. 4, pp. 526-540, 2012.
6. K. Maiese, "Driving neural regeneration through the mammalian target of rapamycin," Neural Regeneration Research, vol. 9, no. 15, pp. 1413-1417, 2014.
7. V. P. Nakka, P. Prakash-babu, and R. Vemuganti, "Crosstalk between endoplasmic reticulum stress, oxidative stress, and autophagy: potential therapeutic targets for acute CNS injuries," Molecular Neurobiology, 2014.
8. A. Q. Nguyen, B. H. Cherry, G. F. Scott, M. Ryou, and R. T. Mallet, "Erythropoietin: powerful protection of ischemic and post-ischemic brain," Experimental Biology and Medicine, vol. 239, no. 11, pp. 1461-1475, 2014.
9. A. Selvamani, M. H. Williams, R. C. Miranda, and F. Sohrabji, "Circulating miRNA profles provide a biomarker for severity of stroke outcomes associated with age and sex in a rat model," Clinical Science, vol. 127, no. 2, pp. 77-89, 2014.
10. X. Xiong, R. Xie, H. Zhang et al., "PRAS40 plays a pivotal role in protecting against stroke by linking the Akt and mTOR pathways," Neurobiology of Disease, vol. 66, pp. 43-52, 2014.
11. World Health Organization, Neurological Disorders: Public Health Challenges, WHO Library Cataloguing-in-Publication Data, 2006.
12. D. Weigel, G. Jürgens, F. Küttner, E. Seifert, and H. Jäckle, "Te homeotic gene fork head encodes a nuclear protein and is expressed in the terminal regions of the Drosophila embryo," Cell, vol. 57, no. 4, pp. 645-658, 1989.
13. K. Maiese, Z. C. Zhao, and C. S. Yan, "'Sly as a FOXO': new paths with forkhead signaling in the brain," Current Neurovascular Research, vol. 4, no. 4, pp. 295-302, 2007.
14. K. Maiese, Z. Z. Chong, Y. C. Shang, and J. Hou, "Clever cancer strategies with FoxO transcription factors," Cell Cycle, vol. 7, no. 24, pp. 3829-3839, 2008.
15. K. Maiese, J. Hou, Z. Z. Chong, and Y. C. Shang, "A fork in the path: developing therapeutic inroads with foxO proteins," Oxidative Medicine and Cellular Longevity, vol. 2, no. 3, pp. 119-129, 2009.
16. Z. Cheng and M. F. White, "Targeting forkhead Box O1 from the concept to metabolic diseases: Lessons from mouse models," Antioxidants and Redox Signaling, vol. 14, no. 4, pp. 649-661, 2011.
17. K. H. Kaestner, W. Knöchel, and D. E. Martínez, "Unifed nomenclature for the winged helix/forkhead transcription factors," Genes and Development, vol. 14, no. 2, pp. 142-146, 2000.
18. K. Maiese, Z. Z. Chong, Y. C. Shang, and J. Hou, "FoxO proteins: cunning concepts and considerations for the cardiovascular system," Clinical Science, vol. 116, no. 3, pp. 191-203, 2009.
19. S. Shao, Y. Yang, G. Yuan, M. Zhang, and X. Yu, "Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction," DNA and Cell Biology, vol. 32, no. 2, pp. 41-49, 2013.
20. K. Maiese, Forkhead Transcription Factors: Vital Elements in Biology and Medicine, vol. 665 of Advances in Experimental Medicine and Biology, Springer Science+Business Media, 2010.
21. K. L. Clark, E. D. Halay, E. Lai, and S. K. Burley, "Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5," Nature, vol. 364, no. 6436, pp. 412-420, 1993.
22. C. Jin, I. Marsden, X. Chen, and X. Liao, "Sequence specifc collective motions in a winged helix DNA binding domain detected by 15N relaxation NMR," Biochemistry, vol. 37, no. 17, pp. 6179-6187, 1998.
23. K. Maiese, Z. Z. Chong, and Y. C. Shang, "OutFOXOing disease and disability: the therapeutic potential of targeting FoxO proteins," Trends in Molecular Medicine, vol. 14, no. 5, pp. 219-227, 2008.
24. E. T. Larson, B. Eilers, S. Menon et al., "A winged-helix protein from sulfolobus turreted icosahedral virus points toward stabilizing disulfde bonds in the intracellular proteins of a hyperthermophilic virus," Virology, vol. 368, no. 2, pp. 249-261, 2007.
25. W. H. Biggs III, W. K. Cavenee, and K. C. Arden, "Identifcation and characterization of members of the FKHR (FOX O) subclass of winged-helix transcription factors in the mouse," Mammalian Genome, vol. 12, no. 6, pp. 416-425, 2001.
26. H. Huang and D. J. Tindall, "Dynamic FoxO transcription factors," Journal of Cell Science, vol. 120, no. 15, pp. 2479-2487, 2007.
27. K. L. Tsai, Y. J. Sun, C. Y. Huang, J. Y. Yang, M. C. Hung, and C. D. Hsiao, "Crystal structure of the human FOXO3a-DBD/DNA complex suggests the efects of post-translational modifcation," Nucleic Acids Research, vol. 35, no. 20, pp. 6984-6994, 2007.
28. Z. Z. Chong, J. Hou, Y. C. Shang, S. Wang, and K. Maiese, "EPO relies upon novel signaling of Wnt1 that requires Akt1, FoxO3a, GSK-3beta, and beta-catenin to foster vascular integrity during experimental diabetes," Current Neurovascular Research, vol. 8, no. 2, pp. 103-120, 2011.
29. M. K. Lehtinen, Z. Yuan, P. R. Boag et al., "A conserved MST-FOXO signaling pathway mediates oxidative-stress responses and extends life span," Cell, vol. 125, no. 5, pp. 987-1001, 2006.
30. P. Scodelaro Bilbao and R. Boland, "Extracellular ATP regulates FoxO family of transcription factors and cell cycle progression through PI3K/Akt in MCF-7 cells," Biochimica et Biophysica Acta, vol. 1830, no. 10, pp. 4456-4469, 2013.
31. L. P. Van Der Heide, M. F. M. Hoekman, and M. P. Smidt, "Te ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation," Biochemical Journal, vol. 380, no. 2, pp. 297-309, 2004.
32. K. Lin, J. B. Dorman, A. Rodan, and C. Kenyon, "daf-16: an HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans," Science, vol. 278, no. 5341, pp. 1319-1322, 1997.
33. S. Ogg, S. Paradis, S. Gottlieb et al., "Te fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans," Nature, vol. 389, no. 6654, pp. 994-999, 1997.
34. K. Maiese, Z. Z. Chong, J. Hall, and Y. C. Shang, "Te 'O' class: crafing clinical care with FoxO transcription factors," Advances in Experimental Medicine and Biology, vol. 665, pp. 242-260, 2009.
35. D. A. M. Salih, A. J. Rashid, D. Colas et al., "FoxO6 regulates memory consolidation and synaptic function," Genes and Development, vol. 26, no. 24, pp. 2780-2801, 2012.
36. M. F. M. Hoekman, F. M. J. Jacobs, M. P. Smidt, and J. P. H. Burbach, "Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain," Gene Expression Patterns, vol. 6, no. 2, pp. 134-140, 2006.
37. 184, independent of nucleo-cytoplasmic shuttling," Biochemical Journal, vol. 391, no. 3, pp. 623-629, 2005.
38. S.-J. Lee, B.-R. Seo, E.-J. Choi, and J.-Y. Koh, "Te role of reciprocal activation of cAbl and Mst1 in the Oxidative death of cultured astrocytes," Glia, vol. 62, no. 4, pp. 639-648, 2014.
39. B. Merkely, E. Gara, Z. Lendvai et al., "Signaling via PI3K/FOXO1A pathway modulates formation and survival of human embryonic stem cell-derived endothelial cells," Stem Cells and Development, vol. 24, no. 7, pp. 869-878, 2015.
40. Y. Zhao, Y. Yu, X. Tian et al., "Association study to evaluate FoxO1 and FoxO3 gene in CHD in Han Chinese," PLoS ONE, vol. 9, no. 1, Article ID e86252, 2014.
41. F. Gilels, S. T. Paquette, J. Zhang, I. Rahman, and P. M. White, "Mutation of foxo3 causes adult onset auditory neuropathy and alters cochlear synapse architecture in mice," Journal of Neuroscience, vol. 33, no. 47, pp. 18409-18424, 2013.
42. J. Hou, S. Wang, Y. C. Shang, Z. Z. Chong, and K. Maiese, "Erythropoietin employs cell longevity pathways of SIRT1 to foster endothelial vascular integrity during oxidant stress," Current Neurovascular Research, vol. 8, no. 3, pp. 220-235, 2011.
43. K. Maiese, F. Li, and Z. Z. Chong, "Erythropoietin in the brain: can the promise to protect be fulflled?" Trends in Pharmacological Sciences, vol. 25, no. 11, pp. 577-583, 2004.
44. S. Peng, S. Zhao, F. Yan et al., "HDAC2 selectively regulates foxo3a-mediated gene transcription during oxidative stress-induced neuronal cell death," Journal of Neuroscience, vol. 35, no. 3, pp. 1250-1259, 2015.
45. Z. Rong, R. Pan, Y. Xu, C. Zhang, Y. Cao, and D. Liu, "Hes-peridin pretreatment protects hypoxia-ischemic brain injury in neonatal rat," Neuroscience, vol. 255, pp. 292-299, 2013.
46. M. E. Chamorro, S. D. Wenker, D. M. Vota, D. C. Vittori, and A. B. Nesse, "Signaling pathways of cell proliferation are involved in the diferential efect of erythropoietin and its carbamylated derivative," Biochimica et Biophysica Acta, vol. 1833, no. 8, pp. 1960-1968, 2013.
47. S. Wang, Z. Z. Chong, Y. C. Shang, and K. Maiese, "WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1," Current Neurovascular Research, vol. 10, no. 1, pp. 54-69, 2013.
48. E. Zeldich, C. Chen, T. A. Colvin et al., "Te neuroprotective efect of Klotho is mediated via regulation of members of the redox system," Te Journal of Biological Chemistry, vol. 289, no. 35, pp. 24700-24715, 2014.
49. A. Jenwitheesuk, C. Nopparat, S. Mukda, P. Wongchitrat, and P. Govitrapong, "Melatonin regulates aging and neurodegener-ation through energy metabolism, epigenetics, autophagy and circadian rhythm pathways," International Journal of Molecular Sciences, vol. 15, no. 9, pp. 16848-16884, 2014.
50. S. Carbajo-Pescador, J. L. Mauriz, A. García-Palomo, and J. González-Gallego, "FoxO proteins: regulation and molecular targets in liver cancer," Current Medicinal Chemistry, vol. 21, no. 10, pp. 1231-1246, 2014.
51. + precursor nicotinamide governs neuronal survival during oxidative stress through protein kinase B coupled to FOXO3a and mitochon-drial membrane potential," Journal of Cerebral Blood Flow and Metabolism, vol. 24, no. 7, pp. 728-743, 2004.
52. Z. Z. Chong and K. Maiese, "Erythropoietin involves the phos-phatidylinositol 3-kinase pathway, 14-3-3 protein and FOXO3a nuclear trafcking to preserve endothelial cell integrity," British Journal of Pharmacology, vol. 150, no. 7, pp. 839-850, 2007.
53. J. Hou, Z. Z. Chong, Y. C. Shang, and K. Maiese, "Early apoptotic vascular signaling is determined by Sirt1 through nuclear shuttling, forkhead trafcking, bad, and mitochondrial caspase activation," Current Neurovascular Research, vol. 7, no. 2, pp. 95-112, 2010.
54. G.-Z. Tao, N. Lehwald, K. Y. Jang et al., "Wnt/γ-catenin signaling protects mouse liver against oxidative stress-induced apoptosis through the inhibition of forkhead transcription factor FoxO3," Journal of Biological Chemistry, vol. 288, no. 24, pp. 17214-17224, 2013.
55. R. M. Uranga, S. Katz, and G. A. Salvador, "Enhanced phos-phatidylinositol 3-kinase (PI3K)/Akt signaling has pleiotropic targets in hippocampal neurons exposed to iron-induced oxida-tive stress," Journal of Biological Chemistry, vol. 288, no. 27, pp. 19773-19784, 2013.
56. C. P. Wong, T. Kaneda, A. H. A. Hadi, and H. Morita, "Ceramicine B, a limonoid with anti-lipid droplets accumulation activity from Chisocheton ceramicus," Journal of Natural Medicines, vol. 68, no. 1, pp. 22-30, 2014.
57. W. Wang, C. Yan, J. Zhang et al., "SIRT1 inhibits TNF-alpha-induced apoptosis of vascular adventitial fbroblasts partly through the deacetylation of FoxO1," Apoptosis, vol. 18, no. 6, pp. 689-701, 2013.
58. J. Hou, Z. Z. Chong, Y. C. Shang, and K. Maiese, "FOXO3a governs early and late apoptotic endothelial programs during elevated glucose through mitochondrial and caspase signaling," Molecular and Cellular Endocrinology, vol. 321, no. 2, pp. 194-206, 2010.
59. K. Maiese, Z. Z. Chong, J. Hou, and Y. C. Shang, "Te vitamin nicotinamide: translating nutrition into clinical care," Molecules, vol. 14, no. 9, pp. 3446-3485, 2009.
60. 1/S phase by inducing p21 via control of FOXO proteins," Te FEBS Journal, vol. 281, no. 4, pp. 1068-1084, 2014.
61. Z. Z. Chog, F. Li, and K. Maiese, "Activating Akt and the brain's resources to drive cellular survival and prevent infammatory injury," Histology and Histopathology, vol. 20, no. 1, pp. 299-315, 2005.
62. C.-Y. Huang, C.-Y. Chan, I.-T. Chou, C.-H. Lien, H.-C. Hung, and M.-F. Lee, "Quercetin induces growth arrest through activation of FOXO1 transcription factor in EGFR-overexpressing oral cancer cells," Journal of Nutritional Biochemistry, vol. 24, no. 9, pp. 1596-1603, 2013.
63. K. Maiese, Z. Z. Chong, and Y. C. Shang, "Mechanistic insights into diabetes mellitus and oxidative stress," Current Medicinal Chemistry, vol. 14, no. 16, pp. 1729-1738, 2007.
64. J. Park, Y. S. Ko, J. Yoon et al., "Te forkhead transcription factor FOXO1 mediates cisplatin resistance in gastric cancer cells by activating phosphoinositide 3-kinase/Akt pathway," Gastric Cancer, vol. 17, no. 3, pp. 423-430, 2014.
65. P. Puthanveetil, A. Wan, and B. Rodrigues, "FoxO1 is crucial for sustaining cardiomyocyte metabolism and cell survival," Cardiovascular Research, vol. 97, no. 3, pp. 393-403, 2013.
66. X.-F. Qi, Y.-J. Li, Z.-Y. Chen, S.-K. Kim, K.-J. Lee, and D.-Q. Cai, "Involvement of the FoxO3a pathway in the ischemia/reperfusion injury of cardiac microvascular endothe-lial cells," Experimental and Molecular Pathology, vol. 95, no. 2, pp. 242-247, 2013.
67. W. Balduini, S. Carloni, and G. Buonocore, "Autophagy in hypoxia-ischemia induced brain injury," Journal of Maternal-Fetal and Neonatal Medicine, vol. 25, supplement 1, pp. 30-34, 2012.
68. L. Bing, J. Wu, J. Zhang, Y. Chen, Z. Hong, and H. Zu, "DHT inhibits the Aγ25-35-induced apoptosis by regulation of seladin-1, survivin, XIAP, bax, and bcl-xl expression through a rapid PI3-K/Akt signaling in C6 glial cell lines," Neurochemical Research, vol. 40, no. 1, pp. 41-48, 2015.
69. Y. C. Shang, Z. Z. Chong, S. Wang, and K. Maiese, "Prevention of beta-amyloid degeneration of microglia by erythropoietin depends on Wnt1, the PI 3-K/mTOR pathway, Bad, and Bcl-xL," Aging, vol. 4, no. 3, pp. 187-201, 2012.
70. Y. C. Shang, Z. Z. Chong, S. Wang, and K. Maiese, "Tuberous sclerosis protein 2 (TSC2) modulates CCN4 cytoprotection during apoptotic amyloid toxicity in microglia," Current Neu-rovascular Research, vol. 10, no. 1, pp. 29-38, 2013.
71. Z.-Y. Chang, M.-K. Yeh, C.-H. Chiang, Y.-H. Chen, and D.-W. Lu, "Erythropoietin protects adult retinal ganglion cells against NMDA-, trophic factor withdrawal-, and TNF-alpha-induced damage," PLoS ONE, vol. 8, no. 1, Article ID e55291, 2013.
72. Z. Z. Chong, J. Q. Kang, and K. Maiese, "AKT1 drives endothelial cell membrane asymmetry and microglial activation through Bcl-xL and caspase 1, 3, and 9," Experimental Cell Research, vol. 296, no. 2, pp. 196-207, 2004.
73. C. Gubern, S. Camós, O. Hurtado et al., "Characterization of Gcf2/Lrrfp1 in experimental cerebral ischemia and its role as a modulator of Akt, mTOR and γ-catenin signaling pathways," Neuroscience, vol. 268, pp. 48-65, 2014.
74. Y. Hong, A. Shao, J. Wang et al., "Neuroprotective efect of hydrogen-rich saline against neurologic damage and apoptosis in early brain injury following subarachnoid hemorrhage: possible role of the Akt/GSK3γ signaling pathway," PLoS ONE, vol. 9, no. 4, Article ID e96212, 2014.
75. A. Jalsrai, T. Numakawa, Y. Ooshima, N. Adachi, and H. Kunugi, "Phosphatase-mediated intracellular signaling contributes to neuroprotection by favonoids of Iris tenuifolia," Te American Journal of Chinese Medicine, vol. 42, no. 1, pp. 119-130, 2014.
76. 2-induced cell death through PI3K-Akt/GSK-3γ pathway and suppression of NF-γγ-cytokines," Drug Design Development and Terapy, vol. 8, pp. 1765-1780, 2014.
77. S. Zara, M. de Colli, M. Rapino et al., "Ibuprofen and lipoic acid conjugate neuroprotective activity is mediated by Ngb/Akt intracellular signaling pathway in alzheimer's disease rat model," Gerontology, vol. 59, no. 3, pp. 250-260, 2013.
78. R. Kimura, M. Okouchi, T. Kato et al., "Epidermal growth factor receptor transactivation is necessary for glucagon-like peptide-1 to protect PC12 cells from apoptosis," Neuroendocrinology, vol. 97, no. 4, pp. 300-308, 2013.
79. E. Russo, F. Andreozzi, R. Iuliano et al., "Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinfammatory cytokine release," Brain, Behavior, and Immunity, vol. 42, pp. 157-168, 2014.
80. Z. Tang, E. Bereczki, H. Zhang et al., "Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease," Journal of Biological Chemistry, vol. 288, no. 22, pp. 15556-15570, 2013.
81. Z. Zhu, J. Yan, W. Jiang et al., "Arctigenin efectively ameliorates memory impairment in Alzheimer's disease model mice targeting both γ-amyloid production and clearance," Journal of Neuroscience, vol. 33, no. 32, pp. 13138-13149, 2013.
82. S. Busch, A. Kannt, M. Kolibabka et al., "Systemic treatment with erythropoietin protects the neurovascular unit in a rat model of retinal neurodegeneration," PLoS ONE, vol. 9, no. 7, Article ID e102013, 2014.
83. Z. Z. Chong, J. Q. Kang, and K. Maiese, "Erythropoietin is a novel vascular protectant through activation of AKt1 and mitochondrial modulation of cysteine proteases," Circulation, vol. 106, no. 23, pp. 2973-2979, 2002.
84. Z. Z. Chong, Y. C. Shang, S. Wang, and K. Maiese, "PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection," PLoS ONE, vol. 7, no. 9, Article ID e45456, 2012.
85. M.-S. Kwon, M.-H. Kim, S.-H. Kim et al., "Erythropoietin exerts cell protective efect by activating PI3k/Akt and MAPK pathways in c6 cells," Neurological Research, vol. 36, no. 3, pp. 215-223, 2014.
86. K. Maiese, Z. Z. Chong, Y. C. Shang, and S. Wang, "Erythro-poietin: new directions for the nervous system," International Journal of Molecular Sciences, vol. 13, no. 9, pp. 11102-11129, 2012.
87. K. Maiese, F. Li, and Z. Z. Chong, "New avenues of exploration for erythropoietin," Journal of the American Medical Association, vol. 293, no. 1, pp. 90-95, 2005.
88. 35 non-transgenic mouse model of Alzheimer's disease," Journal of Psychopharma-cology, vol. 27, no. 11, pp. 1044-1057, 2013.
89. G.-B. Wang, Y.-L. Ni, X.-P. Zhou, and W.-F. Zhang, "Te AKT/mTOR pathway mediates neuronal protective efects of erythropoietin in sepsis," Molecular and Cellular Biochemistry, vol. 385, no. 1-2, pp. 125-132, 2014.
90. E. Arimoto-Ishida, M. Ohmichi, S. Mabuchi et al., "Inhibition of phosphorylation of a Forkhead transcription factor sensitizes human ovarian cancer cells to cisplatin," Endocrinology, vol. 145, no. 4, pp. 2014-2022, 2004.
91. C. K. Won, H. H. Ji, and P. O. Koh, "Estradiol prevents the focal cerebral ischemic injury-induced decrease of forkhead transcription factors phosphorylation," Neuroscience Letters, vol. 398, no. 1-2, pp. 39-43, 2006.
92. C. Chen, Y. Xu, and Y Song, "IGF-1 gene-modifed muscle-derived stem cells are resistant to oxidative stress via enhanced activation of IGF-1R/PI3K/AKT signaling and secretion of VEGF," Molecular and Cellular Biochemistry, vol. 386, no. 1-2, pp. 167-175, 2014.
93. Z. Z. Chong, J.-Q. Kang, and K. Maiese, "Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways," British Journal of Pharmacology, vol. 138, no. 6, pp. 1107-1118, 2003.
94. Z. Z. Chong, S.-H. Lin, J.-Q. Kang, and K. Maiese, "Erythropoietin prevents early and late neuronal demise through modulation of akt1 and induction of caspase 1, 3, and 8," Journal of Neuroscience Research, vol. 71, no. 5, pp. 659-669, 2003.
95. L. Dong, S. Zhou, X. Yang, Q. Chen, Y He, and W. Huang, "Magnolol protects against oxidative stress-mediated neural cell damage by modulating mitochondrial dysfunction and PI3K/Akt signaling," Journal of Molecular Neuroscience, vol. 50, no. 3, pp. 469-481, 2013.
96. Y Jiang, L. Li, B. Liu et al., "Vagus nerve stimulation attenuates cerebral ischemia and reperfusion injury via endogenous cholinergic pathway in rat," PLoS ONE, vol. 9, no. 7, Article ID e102342, 2014.
97. S. H. Kwon, S. I. Hong, S. X Ma, S. Y Lee, and C. G Jang, "3′, 4′, 7-trihydroxyfavone prevents apoptotic cell death in neuronal cells from hydrogen peroxide-induced oxidative stress," Food and Chemical Toxicology, vol. 80, pp. 41-51, 2015.
98. Y Li, M. Zeng, W. Chen et al., "Dexmedetomidine reduces isofurane-induced neuroapoptosis partly by preserving PI3K/Akt pathway in the hippocampus of neonatal rats," PLoS ONE, vol. 9, no. 4, Article ID e93639, 2014.
99. Y Nakazawa, T. Nishino, Y Obata et al., "Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy," Journal of Nephrology, vol. 26, no. 3, pp. 527-533, 2013.
100. L.-L. Pan, X-H. Liu, Y.-L. Jia et al., "A novel compound derived from danshensu inhibits apoptosis via upregulation of heme oxygenase-1 expression in SH-SY5Y cells," Biochimica et Biophysica Acta, vol. 1830, no. 4, pp. 2861-2871, 2013.
101. Y Zhu, G Wu, G. Zhu, C. Ma, and H. Zhao, "Chronic sleep restriction induces changes in the mandibular condylar cartilage of rats: roles of Akt, Bad and Caspase-3," International Journal of Clinical and Experimental Medicine, vol. 7, no. 9, pp. 2585-2592, 2014.
102. Z. Z. Chong, F. Li, and K. Maiese, "Group I metabotropic receptor neuroprotection requires Akt and its substrates that govern FOXO3a, bim, and γ-catenin during oxidative stress," Current Neurovascular Research, vol. 3, no. 2, pp. 107-117, 2006.
103. P. Obexer, K. Geiger, P. F. Ambros, B. Meister, and M. J. Ausserlechner, "FKHRL1-mediated expression of Noxa and Bim induces apoptosis via the mitochondria in neuroblastoma cells," Cell Death and Diferentiation, vol. 14, no. 3, pp. 534-547, 2007.
104. Y. C. Shang, Z. Z. Chong, J. Hou, and K. Maiese, "Wnt1, FoxO3a, and NF-kappaB oversee microglial integrity and activation during oxidant stress," Cellular Signalling, vol. 22, no. 9, pp. 1317-1329, 2010.
105. C. Charvet, I. Alberti, F. Luciano et al., "Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases," Oncogene, vol. 22, no. 29, pp. 4557-4568, 2003.
106. C. S. Yan, Z. C. Zhao, H. Jinling, and K. Maiese, "FoxO3a governs early microglial proliferation and employs mitochondrial depolarization with caspase 3, 8, and 9 cleavage during oxidant induced apoptosis," Current Neurovascular Research, vol. 6, no. 4, pp. 223-238, 2009.
107. M. L. L. Leong, A. C. Maiyar, B. Kim, B. A. O'Keefe, and G. L. Firestone, "Expression of the serum-and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells," Te Journal of Biological Chemistry, vol. 278, no. 8, pp. 5871-5882, 2003.
108. J. J. Song and Y. J. Lee, "Diferential cleavage of Mst1 by caspase-7/-3 is responsible for TRAIL-induced activation of the MAPK superfamily," Cellular Signalling, vol. 20, no. 5, pp. 892-906, 2008.
109. J. Sunayama, F. Tsuruta, N. Masuyama, and Y. Gotoh, "JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3," Journal of Cell Biology, vol. 170, no. 2, pp. 295-304, 2005.
110. H. Matsuzaki, H. Daitoku, M. Hatta, K. Tanaka, and A. Fukamizu, "Insulin-induced phosphorylation of FKHR (Foxo1) targets to proteasomal degradation," Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 20, pp. 11285-11290, 2003.
111. D. R. Plas and C. B. Tompson, "Akt activation promotes degradation of tuberin and FOXO3a via the proteasome," Journal of Biological Chemistry, vol. 278, no. 14, pp. 12361-12366, 2003.
112. Z. Jagani, A. Singh, and R. Khosravi-Far, "FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis," Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1785, no. 1, pp. 63-84, 2008.
113. F. Wang, C.-H. Chan, K. Chen, X. Guan, H.-K. Lin, and Q. Tong, "Deacetylation of FOXO3 by SIRT1 or SIRT2 leads to Skp2-mediated FOXO3 ubiquitination and degradation," Oncogene, vol. 31, no. 12, pp. 1546-1557, 2012.
114. Z. Z. Chong, Y. C. Shang, S. Wang, and K. Maiese, "SIRT1: new avenues of discovery for disorders of oxidative stress," Expert Opinion on Terapeutic Targets, vol. 16, no. 2, pp. 167-178, 2012.
115. Z. Z. Chong, S. Wang, Y. C. Shang, and K. Maiese, "Targeting cardiovascular disease with novel SIRT1 pathways," Future Cardiology, vol. 8, no. 1, pp. 89-100, 2012.
116. K. Maiese, Z. Z. Chong, Y. C. Shang, and S. Wang, "Translating cell survival and cell longevity into treatment strategies with SIRT1," Romanian Journal of Morphology and Embryology, vol. 52, no. 4, pp. 1173-1185, 2011.
117. A. F. Paraíso, K. L. Mendes, and S. H. S. Santos, "Brain activation of SIRT1: role in neuropathology," Molecular Neurobiology, vol. 48, no. 3, pp. 681-689, 2013.
118. Y. Kobayashi, Y. Furukawa-Hibi, C. Chen et al., "SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress," International Journal of Molecular Medicine, vol. 16, no. 2, pp. 237-243, 2005.
119. S. Xiong, G. Salazar, N. Patrushev, and R. W. Alexander, "FoxO1 mediates an autofeedback loop regulating SIRT1 expression," Te Journal of Biological Chemistry, vol. 286, no. 7, pp. 5289-5299, 2011.
120. Y. Akasaki, O. Alvarez-Garcia, M. Saito, B. Caramés, Y. Iwamoto, and M. K. Lotz, "FOXO transcription factors support oxidative stress resistance in human chondrocytes," Arthritis & Rheumatology, vol. 66, no. 12, pp. 3349-3358, 2014.
121. M. C.-T. Hu, D.-F. Lee, W. Xia et al., "IγB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a," Cell, vol. 117, no. 2, pp. 225-237, 2004.
122. H. Matsuzaki, H. Daitoku, M. Hatta, H. Aoyama, K. Yoshi-mochi, and A. Fukamizu, "Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation," Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 32, pp. 11278-11283, 2005.
123. S. S. Myatt and E. W.-F. Lam, "Te emerging roles of forkhead box (Fox) proteins in cancer," Nature Reviews Cancer, vol. 7, no. 11, pp. 847-859, 2007.
124. A. van der Horst and B. M. T. Burgering, "Stressing the role of FoxO proteins in lifespan and disease," Nature Reviews Molecular Cell Biology, vol. 8, no. 6, pp. 440-450, 2007.
125. K. A. Kim, Y. J. Shin, M. Akram et al., "High glucose condition induces autophagy in endothelial progenitor cells contributing to angiogenic impairment," Biological and Pharmaceutical Bulletin, vol. 37, no. 7, pp. 1248-1252, 2014.
126. Y. Liu, S. Shi, Z. Gu et al., "Impaired autophagic function in rat islets with aging," Age, vol. 35, no. 5, pp. 1531-1544, 2013.
127. K. Maiese, Z. Z. Chong, Y. C. Shang, and S. Wang, "Novel directions for diabetes mellitus drug discovery," Expert Opinion on Drug Discovery, vol. 8, no. 1, pp. 35-48, 2013.
128. H. Zhang, C. Duan, and H. Yang, "Defective autophagy in Parkinson's disease: lessons from genetics," Molecular Neurobi-ology, vol. 51, no. 1, pp. 89-104, 2015.
129. Z. C. Zhao, F. Li, and K. Maiese, "Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease," Brain Research Reviews, vol. 49, no. 1, pp. 1-21, 2005.
130. Y. Liu, R. Palanivel, E. Rai et al., "Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high fat diet feeding in mice," Diabetes, vol. 64, no. 1, pp. 36-48, 2014.
131. K. Maiese, "mTOR: driving apoptosis and autophagy for neu-rocardiac complications of diabetes mellitus," World Journal of Diabetes, vol. 6, no. 2, pp. 217-224, 2015.
132. K. Maiese, Z. Z. Chong, S. Wang, and Y. C. Shang, "Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade," International Journal of Molecular Sciences, vol. 13, no. 11, pp. 13830-13866, 2012.
133. E. Mhillaj, M. Morgese, and L. Trabace, "Early life and oxidative stress in psychiatric disorders: what can we learn from animal models?" Current Pharmaceutical Design, vol. 21, no. 11, pp. 1396-1403, 2015.
134. U. Ozel Turkcu, N. Solak Tekin, T. Gokdogan Edgunlu, S. Karakas Celik, and S. Oner, "Te association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients," Gene, vol. 536, no. 1, pp. 129-134, 2014.
135. P. Zolotukhin, Y. Kozlova, A. Dovzhik et al., "Oxidative status interactome map: towards novel approaches in experiment planning, data analysis, diagnostics and therapy," Molecular BioSystems, vol. 9, no. 8, pp. 2085-2096, 2013.
136. G. Harish, A. Mahadevan, N. Pruthi et al., "Characterization of traumatic brain injury in human brains reveals distinct cellular and molecular changes in contusion and pericontusion," Journal of Neurochemistry, 2015.
137. K. Maiese, "SIRT1 and stem cells: in the forefront with cardiovascular disease, neurodegeneration and cancer," World Journal of Stem Cells, vol. 7, no. 2, pp. 235-242, 2015.
138. H. E. Palma, P. Wolkmer, M. Gallio et al., "Oxidative stress parameters in blood, liver, and kidney of diabetic rats treated with curcumin and /or insulin," Molecular and Cellular Biochemistry, vol. 386, no. 1-2, pp. 199-210, 2014.
139. K. Rjiba-Touati, I. Ayed-Boussema, Y. Guedri, A. Achour, H. Bacha, and S. Abid-Essef, "Efect of recombinant human erythropoietin on mitomycin C-induced oxidative stress and genotoxicity in rat kidney and heart tissues," Human & Experimental Toxicology, 2015.
140. J. M. Yousef and A. M. Mohamed, "Prophylactic role of B vitamins against bulk and zinc oxide nano-particles toxicity induced oxidative DNA damage and apoptosis in rat livers," Pakistan Journal of Pharmaceutical Sciences, vol. 28, no. 1, pp. 175-184, 2015.
141. S. Gezginci-Oktayoglu, O. Sacan, S. Bolkent et al., "Chard (Beta vulgaris L. var. cicla) extract ameliorates hyperglycemia by increasing GLUT2 through Akt2 and antioxidant defense in the liver of rats," Acta Histochemica, vol. 116, no. 1, pp. 32-39, 2014.
142. R.-P. Li, Z.-Z. Wang, M.-X. Sun et al., "Polydatin protects learning and memory impairments in a rat model of vascular dementia," Phytomedicine, vol. 19, no. 8-9, pp. 677-681, 2012.
143. X.-Y. Mao, D.-F. Cao, X. Li et al., "Huperzine A ameliorates cognitive defcits in streptozotocin-induced diabetic rats," International Journal of Molecular Sciences, vol. 15, no. 5, pp. 7667-7683, 2014.
144. M. Moghaddasi, S. H. Javanmard, P. Reisi, M. Tajadini, and M. Taati, "Te efect of regular exercise on antioxidant enzyme activities and lipid peroxidation levels in both hippocampi afer occluding one carotid in rat," Te Journal of Physiological Sciences, vol. 64, no. 5, pp. 325-332, 2014.
145. M. M. Muley, V. N. Takare, R. R. Patil, A. D. Kshirsagar, and S. R. Naik, "Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: a comparative evaluation with piracetam and protocatachuic acid," Pharmacology Biochemistry and Behavior, vol. 102, no. 2, pp. 286-293, 2012.
146. A. Srivastava and T. Shivanandappa, "Prevention of hexachlorocyclohexane-induced neuronal oxidative stress by natural antioxidants," Nutritional Neuroscience, vol. 17, no. 4, pp. 164-171, 2014.
147. D. K. Vishwas, A. Mukherjee, C. Haldar, D. Dash, and M. K. Nayak, "Improvement of oxidative stress and immunity by melatonin: an age dependent study in golden hamster," Experimental Gerontology, vol. 48, no. 2, pp. 168-182, 2013.
148. Q. Zhou, C. Liu, W. Liu et al., "Rotenone induction of hydrogen peroxide inhibits mTOR-mediated S6K and 4E-BP1/eIF4E pathways, leading to neuronal apoptosis," Toxicological Sciences, vol. 143, no. 1, pp. 81-96, 2014.
149. C. Bowes Rickman, S. Farsiu, C. A. Toth, and M. Klingeborn, "Dry age-related macular degeneration: mechanisms, therapeutic targets, and imaging," Investigative Ophthalmology and Visual Science, vol. 54, no. 14, pp. ORSF68-ORSF80, 2013.
150. J. A. Miret and S. Munńe-Bosch, "Plant amino acid-derived vitamins: biosynthesis and function," Amino Acids, vol. 46, no. 4, pp. 809-824, 2014.
151. Y.-J. Xu, P. S. Tappia, N. S. Neki, and N. S. Dhalla, "Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants," Heart Failure Reviews, vol. 19, no. 1, pp. 113-121, 2014.
152. T. Kajihara, M. Jones, L. Fusi et al., "Diferential expression of FOXO1 and FOXO3a confers resistance to oxidative cell death upon endometrial decidualization," Molecular Endocrinology, vol. 20, no. 10, pp. 2444-2455, 2006.
153. Z. Cai and L. J. Yan, "Rapamycin, autophagy, and Alzheimer's disease," Journal of Biochemical and Pharmacological Research, vol. 1, no. 2, pp. 84-90, 2013.
154. W. Chen, Y. Sun, K. Liu, and X. Sun, "Autophagy: a double-edged sword for neuronal survival afer cerebral ischemia," Neural Regeneration Research, vol. 9, no. 12, pp. 1210-1216, 2014.
155. Y. Chen, X. Liu, Y. Yin et al., "Unravelling the multifaceted roles of Atg proteins to improve cancer therapy," Cell Proliferation, vol. 47, no. 2, pp. 105-112, 2014.
156. K. Maiese, Z. Z. Chong, Y. C. Shang, and S. Wang, "Targeting disease through novel pathways of apoptosis and autophagy," Expert Opinion on Terapeutic Targets, vol. 16, no. 12, pp. 1203-1214, 2012.
157. J. H. Fox, T. Connor, V. Chopra et al., "Te mTOR kinase inhibitor Everolimus decreases S6 kinase phosphorylation but fails to reduce mutant huntingtin levels in brain and is not neuroprotective in the R6/2 mouse model of Huntington's disease," Molecular Neurodegeneration, vol. 5, no. 1, article 26, 2010.
158. K. Maiese, "Novelapplicationsoftrophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease," Neural Regeneration Research, vol. 10, no. 4, pp. 518-528, 2015.
159. K. Maiese, "Programming apoptosis and autophagy with novel approaches for diabetes mellitus," Current Neurovascular Research, vol. 12, no. 2, pp. 173-188, 2015.
160. R. L. Vidal, A. Figueroa, F. A. Court et al., "Targeting the UPR transcription factor XBP1 protects against Huntington's disease through the regulation of FoxO1 and autophagy," Human Molecular Genetics, vol. 21, no. 10, pp. 2245-2262, 2012.
161. C. He, H. Zhu, H. Li, M.-H. Zou, and Z. Xie, "Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes," Diabetes, vol. 62, no. 4, pp. 1270-1281, 2013.
162. Y. M. Lim, H. Lim, K. Y. Hur et al., "Systemic autophagy insufciency compromises adaptation to metabolic stress and facilitates progression from obesity to diabetes," Nature Communications, vol. 5, article 4934, 2014.
163. H. Vakifahmetoglu-Norberg, H. Xia, and J. Yuan, "Pharmaco-logic agents targeting autophagy," Journal of Clinical Investigation, vol. 125, no. 1, pp. 5-13, 2015.
164. N. Hariharan, Y. Maejima, J. Nakae, J. Paik, R. A. Depinho, and J. Sadoshima, "Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes," Circulation Research, vol. 107, no. 12, pp. 1470-1482, 2010.
165. T. G. Schips, A. Wietelmann, K. Höhn et al., "FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model," Cardiovascular Research, vol. 91, no. 4, pp. 587-597, 2011.
166. J. Shi, N. Yin, L. L. Xuan, C. S. Yao, A. M. Meng, and Q. Hou, "Vam3, a derivative of resveratrol, attenuates cigarette smoke-induced autophagy," Acta Pharmacologica Sinica, vol. 33, no. 7, pp. 888-896, 2012.
167. Y. Fong, Y. Lin, C. Wu et al., "Te antiproliferative and apoptotic efects of sirtinol, a sirtuin inhibitor on human lung cancer cells by modulating Akt/γ-catenin-Foxo3a axis," Te Scientifc World Journal, vol. 2014, Article ID 937051, 8 pages, 2014.
168. X. Guo, Y. Chen, Q. Liu et al., "Ac-cel, a novel antioxidant, protects against hydrogen peroxide-induced injury in PC12 cells via attenuation of mitochondrial dysfunction," Journal of Molecular Neuroscience, vol. 50, no. 3, pp. 453-461, 2013.
169. Z. C. Zhao, F. Li, and K. Maiese, "Oxidative stress in the brain: novel cellular targets that govern survival during neurodegen-erative disease," Progress in Neurobiology, vol. 75, no. 3, pp. 207-246, 2005.
170. B. Favaloro, N. Allocati, V. Graziano, C. di Ilio, and V. de Laurenzi, "Role of apoptosis in disease," Aging, vol. 4, no. 5, pp. 330-349, 2012.
171. J. Folch, F. Junyent, E. Verdaguer et al., "Role of cell cycle reentry in neurons: a common apoptotic mechanism of neuronal cell death," Neurotoxicity Research, vol. 22, no. 3, pp. 195-207, 2012.
172. K. Maiese, Z. Z. Chong, J. Hou, and Y. C. Shang, "Oxidative stress: biomarkers and novel therapeutic pathways," Experimental Gerontology, vol. 45, no. 3, pp. 217-234, 2010.
173. K. Maiese, Z. Z. Chong, Y. C. Shang, and J. Hou, "Novel avenues of drug discovery and biomarkers for diabetes mellitus," Journal of Clinical Pharmacology, vol. 51, no. 2, pp. 128-152, 2011.
174. K. Schutters and C. Reutelingsperger, "Phosphatidylserine targeting for diagnosis and treatment of human diseases," Apopto-sis, vol. 15, no. 9, pp. 1072-1082, 2010.
175. Z. Tang, A. T. Baykal, H. Gao et al., "MTor is a signaling hub in cell survival: a mass-spectrometry-based proteomics investigation," Journal of Proteome Research, vol. 13, no. 5, pp. 2433-2444, 2014.
176. T. Wang, H. Cui, N. Ma, and Y. Jiang, "Nicotinamide-mediated inhibition of SIRT1 deacetylase is associated with the viability of cancer cells exposed to antitumor agents and apoptosis," Oncology Letters, vol. 6, no. 2, pp. 600-604, 2013.
177. Y. Yang, H. Li, S. Hou, B. Hu, J. Liu, and J. Wang, "Tenoncoding RNA expression profle and the efect of lncRNA AK126698 on cisplatin resistance in non-small-cell lung cancer cell," PLoS ONE, vol. 8, no. 5, Article ID e65309, 2013.
178. K. Maiese, "New insights for oxidative stress and diabetes mellitus," Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 875961, 17 pages, 2015.
179. L. Wei, C. Sun, M. Lei et al., "Activation of Wnt/γ-catenin pathway by exogenous Wnt1 protects SH-SY5Y cells against 6-hydroxydopamine toxicity," Journal of Molecular Neuroscience, vol. 49, no. 1, pp. 105-115, 2013.
180. G. Arunachalam, S. M. Samuel, I. Marei, H. Ding, and C. R. Triggle, "Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1," British Journal of Pharmacology, vol. 171, no. 2, pp. 523-535, 2014.
181. T. Nakamura and K. Sakamoto, "Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis," Molecular and Cellular Endocrinology, vol. 281, no. 1-2, pp. 47-55, 2008.
182. C. S. Yan, Z. C. Zhao, J. Hou, and K. Maiese, "Te forkhead transcription factor FOXO3a controls microglial infammatory activation and eventual apoptotic injury through caspase 3," Current Neurovascular Research, vol. 6, no. 1, pp. 20-31, 2009.
183. M. Anitha, C. Gondha, R. Sutlif et al., "GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway," Te Journal of Clinical Investigation, vol. 116, no. 2, pp. 344-356, 2006.
184. W.-H. Zheng, S. Kar, and R. Quirion, "FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling," Journal of Neurochemistry, vol. 80, no. 6, pp. 1049-1061, 2002.
185. W. Zhu, G. N. Bijur, N. A. Styles, and X. Li, "Regulation of FOXO3a by brain-derived neurotrophic factor in diferenti-ated human SH-SY5Y neuroblastoma cells," Molecular Brain Research, vol. 126, no. 1, pp. 45-56, 2004.
186. Z. Tothova, R. Kollipara, B. J. Huntly et al., "FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress," Cell, vol. 128, no. 2, pp. 325-339, 2007.
187. H. Liu, J. Yin, H. Wang et al., "FOXO3a modulates WNT/γ-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells," Cellular Signalling, vol. 27, no. 3, pp. 510-518, 2015.
188. S. Bayod, I. Menella, S. Sanchez-Roige et al., "Wnt pathway regulation by long-term moderate exercise in rat hippocampus," Brain Research, vol. 1543, pp. 38-48, 2014.
189. D. C. Berwick and K. Harvey, "Te regulation and deregulation of Wnt signaling by PARK genes in health and disease," Journal of Molecular Cell Biology, vol. 6, no. 1, pp. 3-12, 2014.
190. K. Maiese, F. Li, Z. Z. Chong, and Y. C. Shang, "Te Wnt signaling pathway: aging gracefully as a protectionist?" Pharmacology and Terapeutics, vol. 118, no. 1, pp. 58-81, 2008.
191. B. Marchetti and S. Pluchino, "Wnt your brain be infamed? Yes, it Wnt!," Trends in Molecular Medicine, vol. 19, no. 3, pp. 144-156, 2013.
192. T. J. Sun, R. Tao, Y. Q. Han, G. Xu, J. Liu, and Y. F. Han, "Terapeutic potential of umbilical cord mesenchymal stem cells with Wnt/beta-catenin signaling pathway pre-activated for the treatment of diabetic wounds," European Review for Medical and Pharmacological Sciences, vol. 18, no. 17, pp. 2460-2464, 2014.
193. Z. Z. Chong, F. Li, and K. Maiese, "Cellular demise and infammatory microglial activation during γ-amyloid toxicity are governed by Wnt1 and canonical signaling pathways," Cellular Signalling, vol. 19, no. 6, pp. 1150-1162, 2007.
194. F. L'Episcopo, C. Tirolo, N. Testa et al., "Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine model of Parkinson's disease," Neurobiology of Disease, vol. 41, no. 2, pp. 508-527, 2011.
195. B. Marchetti, F. L'Episcopo, M. C. Morale et al., "Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/γ-catenin signaling cascade as the common fnal pathway for neuroprotection and self-repair," European Journal of Neuroscience, vol. 37, no. 10, pp. 1550-1563, 2013.
196. C. Gonźalez-Fernández, C. M. Ferńandez-Martos, S. D. Shields, E. Arenas, and F. J. Rodríguez, "Wnts are expressed in the spinal cord of adult mice and are diferentially induced afer injury," Journal of Neurotrauma, vol. 31, no. 6, pp. 565-581, 2014.
197. Z. Z. Chong, Y. C. Shang, J. Hou, and K. Maiese, "Wnt1 neuroprotection translates into improved neurological function during oxidant stress and cerebral ischemia through AKT1 and mitochondrial apoptotic pathways," Oxidative Medicine and Cellular Longevity, vol. 3, no. 2, pp. 153-165, 2010.
198. D. Xu, W. Zhao, G. Pan et al., "Expression of nemo-like kinase afer spinal cord injury in rats," Journal of Molecular Neuroscience, vol. 52, no. 3, pp. 410-418, 2014.
199. F. L'Episcopo, C. Tirolo, N. Testa et al., "Plasticity of subven-tricular zone neuroprogenitors in MPTP (1-Methyl-4-Phenyl-1, 2, 3, 6-tetrahydropyridine) mouse model of Parkinson's disease involves cross talk between infammatory and Wnt/γ-catenin signaling pathways: functional consequences for neuroprotection and repair," Journal of Neuroscience, vol. 32, no. 6, pp. 2062-2085, 2012.
200. B. He, N. Reguart, L. You et al., "Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations," Oncogene, vol. 24, no. 18, pp. 3054-3058, 2005.
201. S. Pandey, "Targeting Wnt-Frizzled signaling in cardiovascular diseases," Molecular Biology Reports, vol. 40, no. 10, pp. 6011-6018, 2013.
202. Y. Xing, X. Zhang, K. Zhao et al., "Benefcial efects of sulindac in focal cerebral ischemia: a positive role in Wnt/γ-catenin pathway," Brain Research, vol. 1482, pp. 71-80, 2012.
203. F. L'Episcopo, M. F. Serapide, C. Tirolo et al., "A Wnt1 regulated Frizzled-1/γ-catenin signaling pathway as a candidate regulatory circuit controlling mesencephalic dopaminergic neuron-astrocyte crosstalk: therapeutical relevance for neuron survival and neuroprotection," Molecular Neurodegeneration, vol. 6, no. 1, article 49, 2011.
204. L. P. Sowers, L. Loo, Y. Wu et al., "Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction," Molecular Psychiatry, vol. 18, no. 10, pp. 1077-1089, 2013.
205. Y. Yang, Y. Su, D. Wang et al., "Tanshinol attenuates the deleterious efects of oxidative stress on osteoblastic diferentiation via wnt/FoxO3a signaling," Oxidative Medicine and Cellular Longevity, vol. 2013, Article ID 351895, 18 pages, 2013.
206. P. Esmaeili Tazangi, S. M. Moosavi, M. Shabani, and M. Haghani, "Erythropoietin improves synaptic plasticity and memory defcits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease," Pharmacology Biochemistry and Behavior, vol. 130, pp. 15-21, 2015.
207. T. Yu, L. Li, T. Chen, Z. Liu, H. Liu, and Z. Li, "Erythropoietin attenuates advanced glycation endproducts-induced toxicity of schwann cells in vitro," Neurochemical Research, vol. 40, no. 4, pp. 698-712, 2015.
208. K. Maiese, J. Hou, Z. Z. Chong, and Y. C. Shang, "Erythropoi-etin, forkhead proteins, and oxidative injury: biomarkers and biology," Te Scientifc World Journal, vol. 9, pp. 1072-1104, 2009.
209. D. J. Klinke II, "Induction of Wnt-inducible signaling protein-1 correlates with invasive breast cancer oncogenesis and reduced type 1 cell-mediated cytotoxic immunity: a retrospective study," PLoS Computational Biology, vol. 10, no. 1, Article ID e1003409, 2014.
210. K. Knoblich, H. X. Wang, C. Sharma, A. L. Fletcher, S. J. Turley, and M. E. Hemler, "Tetraspanin TSPAN12 regulates tumor growth and metastasis and inhibits beta-catenin degradation," Cellular and Molecular Life Sciences, vol. 71, no. 7, pp. 1305-1314, 2014.
211. A. Maeda, M. Ono, K. Holmbeck et al., "WNT1 induced secreted protein-1 (WISP1) : a novel regulator of bone turnover and Wnt signaling," Te Journal of Biological Chemistry, vol. 290, no. 22, pp. 14004-14018, 2015.
212. K. Maiese, "WISP1: clinical insights for a proliferative and restorative member of the CCN family," Current Neurovascular Research, vol. 11, no. 4, pp. 378-389, 2014.
213. V. Murahovschi, O. Pivovarova, I. Ilkavets et al., "WISP1 is a novel adipokine linked to infammation in obesity," Diabetes, vol. 64, no. 3, pp. 856-866, 2015.
214. K. R. Kelly, S. T. Nawrocki, C. M. Espitia et al., "Targeting Aurora A kinase activity with the investigational agent alisertib increases the efcacy of cytarabine through a FOXO-dependent mechanism," International Journal of Cancer, vol. 131, no. 11, pp. 2693-2703, 2012.
215. D. Hoogeboom, M. A. G. Essers, P. E. Polderman, E. Voets, L. M. M. Smits, and B. M. T. Burgering, "Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity," Te Journal of Biological Chemistry, vol. 283, no. 14, pp. 9224-9230, 2008.
216. T. Hosaka, W. H. Biggs III, D. Tieu et al., "Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversifcation," Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2975-2980, 2004.
217. Y. Kamei, S. Miura, M. Suzuki et al., "Skeletal muscle FOXO1 (FKHR) transgenic mice have less skeletal muscle mass, down-regulated type I (slow twitch/red muscle) fber genes, and impaired glycemic control," Te Journal of Biological Chemistry, vol. 279, no. 39, pp. 41114-41123, 2004.
218. D. H. Castrillon, L. Miao, R. Kollipara, J. W. Horner, and R. A. DePinho, "Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a," Science, vol. 301, no. 5630, pp. 215-218, 2003.
219. L. Liu, S. Rajareddy, P. Reddy et al., "Infertility caused by retardation of follicular development in mice with oocyte-specifc expression of Foxo3a," Development, vol. 134, no. 1, pp. 199-209, 2007.
220. N. H. Uhlenhaut and M. Treier, "Forkhead transcription factors in ovarian function," Reproduction, vol. 142, no. 4, pp. 489-495, 2011.
221. W. J. Watkins, A. J. Umbers, K. J. Woad et al., "Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure," Fertility and Sterility, vol. 86, no. 5, pp. 1518-1521, 2006.
222. K. Miyamoto, K. Y. Araki, K. Naka et al., "Foxo3a is essential for maintenance of the hematopoietic stem cell pool," Cell Stem Cell, vol. 1, no. 1, pp. 101-112, 2007.
223. M. Dentice, A. Marsili, R. Ambrosio et al., "Te FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration," Journal of Clinical Investigation, vol. 120, no. 11, pp. 4021-4030, 2010.
224. J. Palazuelos, M. Klingener, and A. Aguirre, "TGFγ signaling regulates the timing of CNS myelination by modulating oligodendrocyte progenitor cell cycle exit through SMAD3/4/FoxO1/Sp1," Te Journal of Neuroscience, vol. 34, no. 23, pp. 7917-7930, 2014.
225. C. Kibbe, J. Chen, G. Xu, G. Jing, and A. Shalev, "FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells," Journal of Biological Chemistry, vol. 288, no. 32, pp. 23194-23202, 2013.
226. M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas, "Oxidative stress antagonizes Wnt signaling in osteoblast precursors by diverting γ-catenin from T cell factor-to forkhead box O-mediated transcription," Te Journal of Biological Chemistry, vol. 282, no. 37, pp. 27298-27305, 2007.
227. H.-D. Chae and H. E. Broxmeyer, "SIRT1 defciency downreg-ulates PTEN/JNK/FOXO1 pathway to block reactive oxygen species-induced apoptosis in mouse embryonic stem cells," Stem Cells and Development, vol. 20, no. 7, pp. 1277-1285, 2011.
228. S. Iyer, L. Han, S. M. Bartell et al., "Sirtuin1 (Sirt1) promotes cortical bone formation by preventing beta-catenin sequestration by FoxO transcription factors in osteoblast progenitors," Te Journal of Biological Chemistry, vol. 289, no. 35, pp. 24069-24078, 2014.
229. E. C. Genin, N. Caron, R. Vandenbosch, L. Nguyen, and B. Malgrange, "Concise review: forkhead pathway in the control of adult neurogenesis," Stem Cells, vol. 32, no. 6, pp. 1398-1407, 2014.
230. A. Domanskyi, H. Alter, M. A. Vogt, P. Gass, and I. A. Vinnikov, "Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance," Frontiers in Cellular Neuroscience, vol. 8, article 275, 2014.
231. D. Lough, H. Dai, M. Yang et al., "Stimulation of the follic-ular bulge lgr5+ and lgr6+ stem cells with the gut-derived human alpha defensin 5 results in decreased bacterial presence, enhanced wound healing, and hair growth from tissues devoid of adnexal structures," Plastic and Reconstructive Surgery, vol. 132, no. 5, pp. 1159-1171, 2013.
232. D.-W. Jung, W.-H. Kim, and D. R. Williams, "Reprogram or reboot: small molecule approaches for the production of induced pluripotent stem cells and direct cell reprogramming," ACS Chemical Biology, vol. 9, no. 1, pp. 80-95, 2014.
233. C.-S. Yang, C. G. Lopez, and T. M. Rana, "Discovery of nonsteroidal anti-infammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation," Stem Cells, vol. 29, no. 10, pp. 1528-1536, 2011.
234. N. Case, Z. Xie, B. Sen et al., "Mechanical activation of γ-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells," Journal of Orthopaedic Research, vol. 28, no. 11, pp. 1531-1538, 2010.
235. J. Heo, E.-K. Ahn, H.-G. Jeong et al., "Transcriptional characterization of Wnt pathway during sequential hepatic diferentia-tion of human embryonic stem cells and adipose tissue-derived stem cells," Biochemical and Biophysical Research Communications, vol. 434, no. 2, pp. 235-240, 2013.
236. R. Castaneda-Arellano, C. Beas-Zarate, A. I. Feria-Velasco, E. W. Bitar-Alatorre, and M. C. Rivera-Cervantes, "From neu-rogenesis to neuroprotection in the epilepsy: signalling by erythropoietin," Frontiers in Bioscience, vol. 19, pp. 1445-1455, 2014.
237. K. Maiese, Z. Z. Chong, F. Li, and Y. C. Shang, "Erythropoietin: elucidating new cellular targets that broaden therapeutic strategies," Progress in Neurobiology, vol. 85, no. 2, pp. 194-213, 2008.
238. K. Maiese, Z. Z. Chong, and Y. C. Shang, "Raves and risks for erythropoietin," Cytokine and Growth Factor Reviews, vol. 19, no. 2, pp. 145-155, 2008.
239. A. M. Messier and R. K. Ohls, "Neuroprotective efects of erythropoiesis-stimulating agents in term and preterm neonates," Current Opinion in Pediatrics, vol. 26, no. 2, pp. 139-145, 2014.
240. A. Palazzuoli, G. Ruocco, M. Pellegrini et al., "Te role of erythropoietin stimulating agents in anemic patients with heart failure: solved and unresolved questions," Terapeutics and Clinical Risk Management, vol. 10, pp. 641-650, 2014.
241. L. Wang, L. Di, and C. T. Noguchi, "Erythropoietin, a novel versatile player regulating energy metabolism beyond the ery-throid system," International Journal of Biological Sciences, vol. 10, no. 8, pp. 921-939, 2014.
242. W. J. Bakker, T. B. van Dijk, M. P.-V. Amelsvoort et al., "Differential regulation of Foxo3a target genes in erythropoiesis," Molecular and Cellular Biology, vol. 27, no. 10, pp. 3839-3854, 2007.
243. N. Kaushal, S. Hegde, J. Lumadue, R. F. Paulson, and K. S. Prabhu, "Te regulation of erythropoiesis by selenium in mice," Antioxidants and Redox Signaling, vol. 14, no. 8, pp. 1403-1412, 2011.
244. S. Srinivasan, M. Anitha, S. Mwangi, and R. O. Heuckeroth, "Enteric neuroblasts require the phosphatidylinositol 3-kinase/Akt/Forkhead pathway for GDNF-stimulated survival," Molecular and Cellular Neuroscience, vol. 29, no. 1, pp. 107-119, 2005.
245. K. Maiese, Z. Z. Chong, Y. C. Shang, and H. Jinling, "Rogue proliferation versus restorative protection: where do we draw the line for Wnt and Forkhead signaling?" Expert Opinion on Terapeutic Targets, vol. 12, no. 7, pp. 905-916, 2008.
246. V. Exil, L. Ping, Y. Yu et al., "Activation of MAPK and FoxO by manganese (Mn) in rat neonatal primary astrocyte cultures," PLoS ONE, vol. 9, no. 5, Article ID e94753, 2014.
247. P. K. Bahia, V. Pugh, K. Hoyland, V. Hensley, M. Rattray, and R. J. Williams, "Neuroprotective efects of phenolic antioxidant tBHQ associate with inhibition of FoxO3a nuclear translocation and activity," Journal of Neurochemistry, vol. 123, no. 1, pp. 182-191, 2012.
248. K. Y. Yoo, S. H. Kwon, C. H. Lee et al., "FoxO3a changes in pyramidal neurons and expresses in non-pyramidal neurons and astrocytes in the gerbil hippocampal CA1 region afer transient cerebral ischemia," Neurochemical Research, vol. 37, no. 3, pp. 588-595, 2012.
249. γγγ1 and FoxO3a in female rat cerebral cortex and PC12 cells," Toxicology Letters, vol. 226, no. 3, pp. 294-302, 2014.
250. A. Wilk, K. Urbanska, S. Yang et al., "Insulin-like growth factor-I-forkhead box O transcription factor 3a counteracts high glucose/tumor necrosis factor-γ-mediated neuronal damage: implications for human immunodefciency virus encephalitis," Journal of Neuroscience Research, vol. 89, no. 2, pp. 183-198, 2011.
251. S. F. Eddy, S. E. Kane, and G. E. Sonenshein, "Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate," Cancer Research, vol. 67, no. 19, pp. 9018-9023, 2007.
252. F. Gao and W. Wang, "MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a," Molecular Medicine Reports, vol. 11, no. 2, pp. 1200-1206, 2015.
253. J. Wang, X. Zheng, G. Zeng, Y. Zhou, and H. Yuan, "Purifed vitexin compound 1 inhibits growth and angiogenesis through activation of FOXO3a by inactivation of Akt in hepatocellular carcinoma," International Journal of Molecular Medicine, vol. 33, no. 2, pp. 441-448, 2014.
254. A. Kafa, S. Bəsíc-Kinda, and N. Pécina-Šlaus, "Te cellular story of dishevelleds," Croatian Medical Journal, vol. 55, no. 5, pp. 459-46667, 2014.
255. F. Li, Z. Z. Chong, and K. Maiese, "Winding through the WNT pathway during cellular development and demise," Histology and Histopathology, vol. 21, no. 1-3, pp. 103-124, 2006.
256. H. Y. Park, K. Toume, M. A. Arai, S. K. Sadhu, F. Ahmed, and M. Ishibashi, "Calotropin: a cardenolide from calotropis gigantea that inhibits Wnt signaling by increasing casein kinase 1alpha in colon cancer cells," ChemBioChem, vol. 15, no. 6, pp. 872-878, 2014.
257. Z.-H. Yang, R. Zheng, Y. Gao, Q. Zhang, and H. Zhang, "Abnormal gene expression and gene fusion in lung adenocarcinoma with high-throughput RNA sequencing," Cancer Gene Terapy, vol. 21, no. 2, pp. 74-82, 2014.
258. C. Tan, S. Liu, S. Tan et al., "Polymorphisms in MicroRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma," PLOS ONE, vol. 10, no. 3, Article ID e0119210, 2015.
259. A. O. Estevez, K. L. Morgan, N. J. Szewczyk, D. Gems, and M. Estevez, "Te neurodegenerative efects of selenium are inhibited by FOXO and PINK1/PTEN regulation of insulin/insulinlike growth factor signaling in Caenorhabditis elegans," Neuro-Toxicology, vol. 41, pp. 28-43, 2014.
260. Y. K. Hong, S. Lee, S. H. Park et al., "Inhibition of JNK/dFOXO pathway and caspases rescues neurological impairments in Drosophila Alzheimer's disease model," Biochemical and Biophysical Research Communications, vol. 419, no. 1, pp. 49-53, 2012.
261. E. Pino, R. Amamoto, L. Zheng et al., "FOXO3 determines the accumulation of γ-synuclein and controls the fate of dopaminergic neurons in the substantia nigra," Human Molecular Genetics, vol. 23, no. 6, pp. 1435-1452, 2014.
262. N. Ferrara, B. Rinaldi, G. Corbi et al., "Exercise training promotes SIRT1 activity in aged rats," Rejuvenation Research, vol. 11, no. 1, pp. 139-150, 2008.
263. R. R. Alcendor, S. Gao, P. Zhai et al., "Sirt1 regulates aging and resistance to oxidative stress in the heart," Circulation Research, vol. 100, no. 10, pp. 1512-1521, 2007.
264. M. Li, J.-F. Chiu, B. T. Mossman, and N. K. Fukagawa, "Down-regulation of manganese-superoxide dismutase through phos-phorylation of FOXO3a by Akt in explanted vascular smooth muscle cells from old rats," Journal of Biological Chemistry, vol. 281, no. 52, pp. 40429-40439, 2006.
265. H. Miyauchi, T. Minamino, K. Tateno, T. Kunieda, H. Toko, and I. Komuro, "Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway," EMBO Journal, vol. 23, no. 1, pp. 212-220, 2004.